Stemline Therapeutics, Inc.

Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells

Home

	The Company
	Stemline Therapeutics, Inc. is a clinical stage biotechnology company developing oncology compounds directed towards cancer stem cell targets.

	Platform
	Stemline Therapeutics has developed a Discovery Platform called "StemScreen^®" to identify novel compounds that target and kill CSCs.

News
&
Events

3/11/2009
Stemline CEO is invited speaker at New Frontiers in Cancer Drug Development

4/9/2008
Stemline raises $12.5 million

12/10/2007
L.A. Times cites Stemline and CEO